Karen Gallagher

Vice President, Product Strategy, AAV Systemic Asset Program Leadership at Spark Therapeutics

Karen Gallagher has extensive experience in program management, strategic alliances, and clinical operations within the pharmaceutical industry. Karen currently serves as the Vice President of Product Strategy at Spark Therapeutics, Inc., overseeing the AAV Systemic Asset Program. Prior to their current role, Karen held various leadership positions at companies like Teva Pharmaceuticals, Shire, Johnson & Johnson, Pfizer, Procter & Gamble, and ICON Clinical Research. Karen holds a Master's degree in Pharmacy from the University of Florida, a Bachelor's degree in Political Science from Ursinus College, and a Bachelor's degree in Nursing from Widener University.

Links

Previous companies

Procter & Gamble logo
Johnson & Johnson logo
ICON logo
Pfizer logo
Teva Pharmaceutical Industries logo

Timeline

  • Vice President, Product Strategy, AAV Systemic Asset Program Leadership

    April, 2019 - present

  • Vice President, Head Of Program Management & R&d Operations

    July, 2018

  • Head Of R&d Operations

    September, 2017